期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

他汀类药物与冠状动脉粥样硬化性心脏病的一级预防及其作用机制 被引量：6

Statins and primary prevention of coronary heart disease and its mechanism
下载PDF
导出
摘要 一级预防也称病因预防或初级预防，主要是针对心血管病致病因子采取的措施，达到预防疾病发生的目的：主要是面向人群，为没有或虽有危险因素存在，但疾病尚未发生者进行的预防。自20世纪70年代首次由Endo等研究提出他汀类药物的降脂作用与在心血管疾病的治疗中扮演着重要角色以来，对他汀类药物的研究逐渐深入。
作者 董道然 曾玉杰
机构地区 中日友好医院心内科
出处 《中国心血管病研究》 CAS 2012年第3期221-223,共3页 Chinese Journal of Cardiovascular Research
关键词 冠状动脉疾病 他汀 一级预防 作用机制 Coronary artery disease Statins Primary prevention Mechanism
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

二级参考文献57

  • 1吴旻,李玉光,闫纯英,张钰,许端敏.基质金属蛋白酶和氧化应激在大鼠动脉粥样硬化中的表达[J].中国心血管病研究,2007,5(1):55-57. 被引量：8
  • 2Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8.
  • 3Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, Isner JM, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002; 30: 967-72.
  • 4Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T, et al. Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 2006; 47: 1227-37.
  • 5Imanishi T, Hano T, Sawamura T, Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 2004; 31: 407-13.
  • 6Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-9.
  • 7Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBOJ 1999; 18: 3964-72.
  • 8Levadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001;108: 399-405.
  • 9Ma FX, Han ZC. Akt signaling and its role in postnatal neovascularization. Histol Histopathol 2005; 20: 275-81.
  • 10Fulton D, Gratton JR McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597-601.

共引文献63

同被引文献73

  • 1The Collaborative Research Group for the Second Multi-center Survey of Clinical Management of Dyslipidemia in China.第二次中国临床血脂控制达标率及影响因素多中心协作研究[J].中华心血管病杂志,2007,35(5):420-427. 被引量：127
  • 2张秋颖,王秋安.小议药师与患者的沟通[J].河南中医,2007,27(8):84-85. 被引量：6
  • 3Urowitz MB, Bookman AA, Koehler BE, et al. The bimodalmortality pattern of systemic lupus erythematosus. Am J Med,1976,60:221-225.
  • 4Bessant R, Hingorani A, Patel L, et al. Risk of coronary heartdisease and stroke in a large british cohort of patients with sys-temic lupus erythematosus. Rheumatology (xford), 2004,43 :924-929.
  • 5Manzi S,Meilahn EN, Rairie JE, et al. Age-specific incidencerates of myocardial infarction and angina in women with systemiclupus erythematosus: Comparison with the Framingham study. AmJ Epidemiol, 1997,145 : 408-415.
  • 6Bruce IN, Urowitz MB, Gladman DD, et al. Risk factors forcoronary heart disease in women with systemic lupus erythemato-sus: the Toronto Risk Factor Study. Arthritis Rheum, 2003,48 :3159-3167.
  • 7Magder LS, Petri M. Incidence and risk factors for adverse car-diovascular events among patients with systemic lupus erythe-matosus. Am J Epidemiol, 2012,176:708-719.
  • 8Esdaile JM, Abrahamowicz M, Grodzicky T, et al. TraditionalFramingham risk factors fail to fully account for acceleratedatherosclerosis in systemic lupus erythematosus. Arthritis Rheum,2001,44:2331-2337.
  • 9Roman MJ, Shanker BA, Davis A, et al. Prevalence and corre-lates of accelerated atherosclerosis in systemic lupus eiythemato-sus. N Engl J Med, 2003,349 : 2399-406.
  • 10G6mez-Zumaquero JM, Tinahones FJ,De Ram6n E,et al. Asso-ciation of biological markers of activity of systemic lupus erythe-matosus with levels of anti-oxidized low-density lipoprotein anti-bodies. Rheumatology (Oxford), 2004,43:510-513.

引证文献6

二级引证文献46

中国心血管病研究
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部